Mode
Text Size
Log in / Sign up

Metastases

Subtypes of Metastases

Lymph Node Metastasis 1 Metastasis 1

3 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Metastases

11 trials tracked for Metastases: 5 in phase 3 or 4 and 2 with published results. The most-cited published study has 164 citations.

11Trials tracked
5Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 3 5 Phase 2 5 Other / NA 1
  1. Phase 3 QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas Completed · 164 cited
  2. Phase 3 Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast Cancer Completed · 10 cited
  3. Phase 3 MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma Completed
  4. Phase 3 Evaluating Panitumumab (ABX-EGF) Plus Best Supportive Care Versus Best Supportive Care in Patients With Metastatic Colorectal Cancer Completed
  5. Phase 3 Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer Completed
  6. Phase 2 Panitumumab (ABX-EGF) Monotherapy in Patients With Metastatic Colorectal Cancer Completed
Show 5 more trials
  1. Phase 2 PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer) Completed
  2. Phase 2 Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy Completed
  3. Phase 2 Everolimus After (Chemo)Embolization for Liver Metastases From Digestive Endocrine Tumors Completed
  4. Phase 2 Denosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast Cancer Completed
  5. N/A Patterns of Care and Outcomes in METAstatic Soft Tissue SARComa Completed

Showing the 11 most-cited and recently-updated of 11 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.